Insider · CIK 0001777517
G. Walmsley Graham
Files at AKRO (Akero Therapeutics, Inc.), OLMA (Olema Pharmaceuticals, Inc.). First filing Nov 26, 2024, latest Mar 27, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OLMA: Olema Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | AKRObuy Akero Therapeutics, Inc. | $8.8M 200,000 shares | +20% | - | |
| 46Moderate | AKRObuy Akero Therapeutics, Inc. | $9.6M 200,000 shares | +25% | - | |
| 48Moderate | OLMAbuy Olema Pharmaceuticals, Inc. | $4.7M 700,761 shares | - | - | |
| 75Notable | Olema Pharmaceuticals, Inc. | $4.7M 700,761 shares | -100% | - | |
| 55Moderate | OLMAbuy Olema Pharmaceuticals, Inc. | $4.7M 700,761 shares | +99% | - | |
| 75Notable | Olema Pharmaceuticals, Inc. | $4.7M 700,761 shares | -100% | - | |
| 60Notable | OLMAsell Olema Pharmaceuticals, Inc. | $17M 1,175,000 shares | -84% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | AKRO Akero Therapeutics, Inc. | POpen-market purchase Common Stockindirect: See Footnote 1 | +91,309 | $44.75 | $4.1M | 1,091,309 | Mar 27, 2025 |
| Mar 26, 2025 | AKRO Akero Therapeutics, Inc. | POpen-market purchase Common Stockindirect: See Footnote 1 | +58,691 | $43.01 | $2.5M | 1,150,000 | Mar 27, 2025 |
| Mar 27, 2025 | AKRO Akero Therapeutics, Inc. | POpen-market purchase Common Stockindirect: See Footnote 1 | +50,000 | $43.55 | $2.2M | 1,200,000 | Mar 27, 2025 |
| Jan 30, 2025 | AKRO Akero Therapeutics, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +200,000 | $48.00 | $9.6M | 1,000,000 | Feb 7, 2025 |
| Dec 13, 2024 | OLMA Olema Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: See note | -700,761 | $6.75 | $4.7M | 0 | Dec 18, 2024 |
| Dec 13, 2024 | OLMA Olema Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: See note | +700,761 | $6.75 | $4.7M | 700,761 | Dec 18, 2024 |
| Dec 17, 2024 | OLMA Olema Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: See note | -700,761 | $6.75 | $4.7M | 0 | Dec 17, 2024 |
| Dec 17, 2024 | OLMA Olema Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: See note | -700,761 | $6.75 | $4.7M | 1,408,875 | Dec 17, 2024 |
| Jun 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: See note | -700,000 | $14.85 | $10M | 700,761 | Nov 26, 2024 |
| Jun 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: See note | -475,000 | $14.85 | $7.1M | 708,114 | Nov 26, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.